Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market

Filed Under: Pharma Tagged With: , ,

Mitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open up for…
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of Oligonucleotides…
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…